Trinseo Valuation

Is 3XD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 3XD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 3XD (€3.28) is trading below our estimate of fair value (€53.51)

Significantly Below Fair Value: 3XD is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 3XD?

Key metric: As 3XD is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 3XD. This is calculated by dividing 3XD's market cap by their current revenue.
What is 3XD's PS Ratio?
PS Ratio0.03x
SalesUS$3.53b
Market CapUS$122.49m

Price to Sales Ratio vs Peers

How does 3XD's PS Ratio compare to its peers?

The above table shows the PS ratio for 3XD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.5x
SIM0 SIMONA
0.6xn/a€342.0m
IBU IBU-tec advanced materials
0.8x19.2%€40.6m
NTG Nabaltec
0.6x4.5%€120.6m
2HRA H&R GmbH KGaA
0.1x2.7%€129.2m
3XD Trinseo
0.03x5.0%€122.5m

Price-To-Sales vs Peers: 3XD is good value based on its Price-To-Sales Ratio (0x) compared to the peer average (0.5x).


Price to Sales Ratio vs Industry

How does 3XD's PS Ratio compare vs other companies in the DE Chemicals Industry?

4 CompaniesPrice / SalesEstimated GrowthMarket Cap
Industry Avg.1.0x4.3%
3XD Trinseo
0.03x5.0%US$122.49m
2HRA H&R GmbH KGaA
0.1x2.7%US$135.97m
NSAK OTI Greentech
0.03xn/aUS$601.13k
3XD 0.0xIndustry Avg. 1.0xNo. of Companies6PS00.40.81.21.62+
4 CompaniesEstimated GrowthMarket Cap
Industry Avg.1.0x35.1%
3XD Trinseo
0.03xn/aUS$122.49m
No more companies

Price-To-Sales vs Industry: 3XD is good value based on its Price-To-Sales Ratio (0x) compared to the European Chemicals industry average (1x).


Price to Sales Ratio vs Fair Ratio

What is 3XD's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

3XD PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.03x
Fair PS Ratio0.3x

Price-To-Sales vs Fair Ratio: 3XD is good value based on its Price-To-Sales Ratio (0x) compared to the estimated Fair Price-To-Sales Ratio (0.3x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 3XD forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€3.28
€4.28
+30.5%
11.1%€4.76€3.80n/a4
Nov ’25€3.98
€4.27
+7.3%
28.0%€5.54€2.31n/a4
Oct ’25€4.30
€5.10
+18.7%
42.8%€8.96€2.24n/a5
Sep ’25€3.54
€4.57
+29.1%
52.0%€8.96€2.24n/a5
Aug ’25€2.40
€4.78
+99.1%
49.3%€9.33€2.80n/a5
Jul ’25€1.87
€4.78
+155.5%
49.3%€9.33€2.80n/a5
Jun ’25€2.74
€5.10
+86.2%
41.7%€9.24€3.47n/a5
May ’25€2.60
€5.65
+117.2%
33.3%€9.41€4.71n/a5
Apr ’25€3.10
€5.57
+79.7%
33.3%€9.29€4.64n/a5
Mar ’25€4.06
€5.57
+37.2%
33.3%€9.29€4.64n/a5
Feb ’25€5.45
€6.97
+27.8%
16.9%€9.29€6.04n/a5
Jan ’25€7.70
€6.97
-9.5%
16.9%€9.29€6.04n/a5
Dec ’24€5.20
€9.58
+84.3%
62.2%€21.51€6.55n/a5
Nov ’24€5.75
€11.16
+94.0%
48.4%€21.75€6.62€3.985
Oct ’24€7.55
€16.09
+113.1%
28.6%€21.76€9.46€4.305
Sep ’24€9.50
€16.17
+70.2%
23.2%€21.13€11.94€3.545
Aug ’24€15.70
€17.97
+14.4%
23.1%€24.90€14.23€2.405
Jul ’24€11.50
€20.63
+79.4%
33.8%€31.94€14.60€1.875
Jun ’24€11.40
€23.06
+102.3%
30.9%€32.29€14.76€2.745
May ’24€15.70
€25.04
+59.5%
19.5%€32.27€18.44€2.606
Apr ’24€18.50
€25.04
+35.4%
19.5%€32.27€18.44€3.106
Mar ’24€21.60
€25.89
+19.9%
17.1%€32.87€18.78€4.067
Feb ’24€26.00
€25.36
-2.5%
23.7%€36.80€18.40€5.457
Jan ’24€20.80
€25.29
+21.6%
23.6%€38.70€19.35€7.707
Dec ’23€23.20
€25.29
+9.0%
23.6%€38.70€19.35€5.207
Nov ’23€18.60
€25.30
+36.0%
27.2%€40.94€20.47€5.757

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies